Reinduction chemotherapy regimen involved decitabine and cladribine improves the prognosis of patients with relapsed or refractory acute myeloid leukemia: A preliminary study-MedSci.cn

Reinduction chemotherapy regimen involved decitabine and cladribine improves the prognosis of patients with relapsed or refractory acute myeloid leukemia: A preliminary study

Hui, Y; Li, Y; Tong, XW; Huang, LF; Mao, X; Huang, L; Zhang, DH

Zhang, DH (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hematol, Tongji Med Coll, 1095 Jie Fang Ave, Wuhan 430030, Hubei, Peoples R China.

INTERNATIONAL JOURNAL OF CANCER, 2021; 149 (4): 901

Abstract

Relapsed/refractory acute myeloid leukemia (R/R-AML) is characterized by a high incidence, short survival and poor prognosis. Presently, no unified ef......

Full Text Link